Skip to main content

Yervoy News (Page 2)

FDA Medwatch Alert: Yervoy (ipilimumab): Risk Evaluation and Mitigation Strategy (REMS) - Severe Immune-Mediated Adverse Reactions

ISSUE: Bristol-Myers Squibb informed healthcare professionals about the risk evaluation and mitigation strategy (REMS), developed in collaboration with FDA, that is required to ensure that the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Renal Cell Carcinoma, Melanoma, Colorectal Cancer

Yervoy patient information at Drugs.com